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Abstract
Iron–sulfur clusters are ubiquitous inorganic co-factors that contribute to a wide range of cell pathways including the main-
tenance of DNA integrity, regulation of gene expression and protein translation, energy production, and antiviral response. 
Specifically, the iron–sulfur cluster biogenesis pathways include several proteins dedicated to the maturation of apoproteins 
in different cell compartments. Given the complexity of the biogenesis process itself, the iron–sulfur research area consti-
tutes a very challenging and interesting field with still many unaddressed questions. Mutations or malfunctions affecting the 
iron–sulfur biogenesis machinery have been linked with an increasing amount of disorders such as Friedreich’s ataxia and 
various cardiomyopathies. This review aims to recap the recent discoveries both in the yeast and human iron–sulfur cluster 
arena, covering recent discoveries from chemistry to disease.
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Abbreviations
Aft  Activator of ferrous transport
Atm1  ATP-binding cassette (ABC) transporter
Cfd1  Complement factor D
CIA  Cytosolic iron–sulfur cluster assembly
Erv1  Essential for respiration and vegetative 
growth 1
GFER  Growth factor, augmenter of liver 
regeneration
Grx/GLRX  Glutaredoxin
GSH  Reduced glutathione
GSSG  Oxidised glutathione
HSP9  Heat shock protein 9
HSC20  Heat shock cognate protein 20
IRP  Iron regulatory proteins
IRES  Iron-responsive elements
ISC  Iron–sulfur cluster
Isu1  Iron–sulfur cluster assembly scaffold 
protein
Jac1  J-type accessory chaperone 1
Nbp35/NUBP1  Nucleotide-binding protein
Rad3  TFIIH/NER complex ATP-dependent 
5′–3′ DNA helicase subunit RAD3
Ssq1  Stress-seventy sub-family Q 1
SUF  Sulfur mobilization system
XPD  Xeroderma pigmentosum group D 
helicase
Yap5  Yeast AP-5
Introduction
Iron–sulfur clusters are metal prosthetic groups, synthesized 
and utilised in different cell compartments. They are present 
in nearly all organisms and required for a variety of protein 
biological functions, such as enzyme activity, protein regula-
tion, and translation [1–6]. Fe–S clusters are considered to 
be among the most ancient catalysts, a concept that is sup-
ported by the elevated iron and sulfur levels in the environ-
ment and their unique characteristics, including the electron 
charge transfer activity and the formation into complexes 
[7, 8].
Despite their abundance, one of the many challenges 
which this field had to face early on was the detection of 
the clusters on proteins. The isolation of an intact complex 
of the protein with the cluster has been a difficult task, as 
the cluster can easily dissociate or change its redox state. 
These issues along with the lack of additional structural 
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protein information were the cause for slow paced study of 
the clusters.
Consequently, although Fe–S clusters have been studied 
for decades, many aspects of their synthesis, transfer, incor-
poration on proteins, and role have still to be understood 
[9–11]. Even though Fe–S clusters can be found in differ-
ent chemical structures, all of them derive from iron ions 
and sulfide (Fig. 1). The simplest form that can be found in 
nature is [2Fe–2S] and duplication of this form results to 
the cubic cluster [4Fe–4S]. In addition, loss of one Fe ions 
of that form leads to the non-symmetrical [3Fe–4S] struc-
ture [10]. Finally, another form is composed of a cubane 
[4Fe–4S] together with a [4Fe–3S] cluster resulting in the 
[8Fe–7S] cluster [3, 12].
These inorganic moieties pose an excellent example of 
co-factors that are highly reactive and thus suitable for many 
catalytic reactions. However, this feature is the main cause 
of their susceptibility as they are also prone to oxidation 
that leads to the Fe–S cluster inactivation. Many enzymes, 
such as DNA-binding proteins, have traded over iron for 
zinc or other metals that are less sensitive to oxidation and 
thus less likely to cause toxicity. Specifically, it was origi-
nally believed that glycosylases were the only DNA-binding 
enzymes that utilise Fe–S clusters [2, 13]. However, in 2006, 
another DNA enzyme, the helicase XfPD (Rad3 in Saccha-
romyces cerevisiae) was shown to bind to an iron–sulfur 
cluster within the catalytic domain of the protein. This 
finding indicated a role for iron–sulfur clusters in sensing 
DNA disruption (Fig. 1) and led to discovering more DNA-
binding proteins that use Fe–S clusters, including all DNA 
polymerases [14–16]. The role of Fe–S clusters in process-
ing nucleic acids is still not fully understood, although they 
are indispensable for enzyme activity. The main question 
focuses on why these metal moieties are preferred over 
others, when the risk of toxicity or DNA damage by iron is 
so great. This is a critical research area that can link Fe–S 
cluster chemistry with protein function, DNA damage, and 
subsequently diseases.
In this review, we will first describe the steps for the Fe–S 
biogenesis in the model organism Saccharomyces cerevisiae 
(budding yeast) and expand onto the relevant mechanisms 
in mammalian cells covering the recent information on the 
transport and delivery of the clusters into apoproteins. Given 
the importance that mitochondria have on Fe–S cluster for-
mation, we will discuss any putative links between that 
pathway and the organelle’s biogenesis. Finally, some of the 
main human disorders caused by defects in proteins under-
pinning the Fe–S biogenesis machinery will be discussed.
Fe–S cluster pathways: from yeast 
to mammalian cells
For decades, it was presumed that Fe–S clusters are incorpo-
rated on apoproteins in a spontaneous fashion, a theory that 
was proved insufficient, since in vitro successful integration 
required toxic Fe levels. A more plausible theory was that 
there are specific pathways responsible for the biosynthesis 
of Fe–S for the final delivery to apoproteins. Later, studies 
on the fields of iron chemistry, metabolism, and oxidative 
stress provided the evidence that changed the perception of 
Fe–S biosynthesis [17–19]. One of the main breakthroughs 
was the investigation of the enzyme nitrogenase [20], that 
catalyses the reduction of dinitrogen, known as ‘nitrogen 
fixation’. Dennis Dean and colleagues performed genetic and 
biochemical studies on the Gram-negative facultative anaer-
obe Klebsiella pneumoniae bacterium identifying genes 
involved in the nitrogen fixation process. The comparison 
Fig. 1  Iron–sulfur clusters and 
proteins. a Example structures 
of known and well-charac-
terised Fe/S clusters. Blue; 
Fe, black; sulfur. b Crystal 
structure of XPD helicase (PDB 
ID 3CRV)  and c ferredoxin 
2 (PDB ID 4ZHO) with a 
[4Fe–4S] and [2Fe–2S] clusters 
bound (black sticks)
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between the sequences of the nifUSV gene clusters from K. 
pneumoniae and Azotobacter vinelandii revealed identical 
organization of the genomes as well as a high degree of 
sequence homology [21]. The studies made on A. vinelandii 
were crucial to the discovery of Fe–S biogenesis mecha-
nism as three operons dedicated to the Fe–S biogenesis 
were found, one of them being the nif operon, involved in 
the biogenesis of nitrogenase [22]. Since then, the iron–sul-
fur cluster synthesis and assembly pathways have begun to 
be described, in addition to the sensing iron-level mecha-
nisms, providing a better understanding of the complicated 
chemistry of iron [23, 24]. Bacteria Fe–S cluster biogenesis 
machineries have been reviewed elsewhere [25, 26], and 
thus, are not the focus of this review. The data summarised 
below have been acquired from studies mainly in yeast and 
mammalian cell lines. Since the pathways are conserved, we 
only shortly refer to the yeast system and analyse, in more 
detail, the mammalian as a way to introduce the relevance 
and implication of this co-factor in a wide range of diseases.
Fe–S clusters in Saccharomyces cerevisiae
Iron–sulfur cluster proteins can be found in most cell com-
partments from mitochondria to the nucleus. Due to their 
role complexity, the need for a simple model system to study 
these molecules was apparent. The yeast S. cerevisiae has 
been used in the past thoroughly to study complex biologi-
cal processes as a simple, easy to grow eukaryotic model 
organism and provided the necessary platform for the inves-
tigation of the highly conserved Fe–S pathways.
Free iron (as well as sulfides) can be toxic to the cell [27, 
28], rendering its regulation, uptake, and assembly essential 
processes that should be controlled constantly. Three biosyn-
thesis pathways have been described so far that contribute 
to that end; two at the mitochondrial level [iron–sulfur clus-
ter (ISC)] and one at the cytosolic compartments [cytosolic 
iron–sulfur cluster assembly (CIA)] (Fig. 2) [2, 11, 29, 30]. 
In the mitochondrial matrix, the first stage of the ISC path-
way comprises of the iron–sulfur cluster synthesis, with the 
extraction of sulfur from cysteine. This reaction is catalysed 
by the enzyme cysteine desulfurase, Nfs1. Next is the cluster 
assembly, a step that is accomplished on the scaffold protein 
Isu1 by a group of enzymes that utilise the available iron 
and sulfur, as shown in Fig. 2. The Fe–S cluster is subse-
quently released from the scaffold protein and transferred 
by chaperones to glutaredoxin 5 (Grx5). The cooperation 
between Grx5 and co-chaperones, Jac1 and Ssq1, leads to 
the final incorporation of the clusters onto the target apopro-
teins [31]. Apart from the simple cluster, the mitochondrial 
ISC machinery can also produce the more complex forms 
that are required for the function of several proteins in the 
organelle. The synthesis of a cubic cluster from the initially 
formed [2Fe–2S] requires a conversion reaction occurring 
later in the pathway. Alternatively, the [2Fe–2S] clusters fol-
low the putative mitochondrial export route to be used by 
the CIA system.
The exported form of the cluster has been the subject of 
many studies over the years; and despite substantial progress 
Fig. 2  Fe/S cluster biogenesis. 
The process includes three dif-
ferent stages, two in mitochon-
dria (A and B), and one in the 
cytosol (C). In the mitochon-
drial matrix, the ISC machin-
ery (A) is responsible for the 
formation of the clusters and the 
maturation of the apoproteins. 
An unknown compound (X-S) 
is exported from the matrix (B) 
through the ISC export pathway. 
In the cytosol (C), the CIA 
machinery takes over for the 
incorporation of the clusters in 
the proteins
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in the field, the identity of the exported species remains 
speculative. Originally, it was shown that the export pathway 
involves three components, one membrane channel protein 
(Atm1), one sulfhydryl oxidase (Erv1), and one reducing 
factor [glutathione (GSH)]. The equivalent human homo-
logues will be reviewed later. The most recent data show 
that the exported cluster could be stabilised by glutathione 
molecules [32, 33]. Specifically, crystal structures revealed 
that reduced glutathione (GSH) was associated with both 
the yeast and bacterial pore Atm1, whereas bacterial Atm1 
could also bind to oxidised glutathione (GSSG). However, 
there are still no concrete data of transported conjugates of 
glutathione and iron–sulfur cluster, rendering the real nature 
compound elusive. In addition, there are studies that contra-
dict the presence of an export pathway, based on the incon-
clusive evidence of an exported cluster from mitochondria 
and the cytosolic presence of the initial proteins involved in 
the cluster formation [34].
In the cytoplasm, a [2Fe–2S] cluster that is in turn bound 
by the two monothiol glutaredoxins, Grx3 and Grx4 [35]. 
The two proteins act as a homodimer coordinating the clus-
ter with the assistance of two glutathione molecules [35, 
36]. The Fe–S cluster can be further used for the biogenesis 
of cytosolic and nuclear Fe–S proteins. Specifically, the two 
proteins Tah18–Dre2 provide the necessary electron donors 
to deliver the assembly of the cluster on the first scaffold 
protein complex of the CIA machinery, Cfd1–Nbp35 [37, 
38]. Next, the cluster is transferred through the pathway 
molecules to the cytosolic apoproteins for their maturation 
(Fig. 2).
Fe–S clusters in mammalian cells
As noted by the fact that the assembly involved in the bio-
genesis of Fe–S clusters is highly conserved throughout evo-
lution, mammalian Fe–S cluster biogenesis follows a path 
that resembles both the yeast and bacterial pathways. The 
bacterial classical system is mainly regulated by the Isc gene 
[39] and homologues of the proteins encoded by this gene 
can be found in mammals. In this section, we will focus on 
the mammalian biogenesis machinery as a basis to show its 
involvement in several diseases such as neurodegenerative 
disorders.
The process of the de novo synthesis of Fe–S clusters 
takes place in mitochondria and is driven by the ISC machin-
ery. Furthermore, it has been suggested that Fe–S biogenesis 
can also take place in the cytosol and the nucleus [40–42]. 
The synthesis starts with the delivery of both the sulfur and 
iron ions onto the scaffold protein ISCU [43]. The sulfur is 
provided by a cysteine desulfurase (NFS1) which removes 
and delivers it from l-cysteine onto ISCU. This delivery 
process is driven by the formation of transient persulfide on 
the active cysteine of NFS1, which forms a complex with 
ISD11 (also known as LYRM4) and the mitochondrial acyl 
carrier protein (ACP) [44]. The importance of the NFS1 
and ISD11 has been shown by the inefficient maturation of 
Fe–S proteins in HeLa cells with depleted NFS1 and the 
accumulation of ferric iron and inactivation of aconitase 
in cells with downregulated ISD11, respectively [45, 46]. 
An allosteric regulation role for the sulfur transfer onto the 
ISCU–NFS1–ISD11–ACP complex has been suggested for 
the mammalian frataxin (FXN) [47, 48]. The iron source 
for the cluster assembly is not known yet; however, FXN 
has also been proposed as one of the iron entry regulators 
during the [4Fe–4S] cluster formation [49]. It is interest-
ing to note that unlike the mammalian FXN, its bacterial 
homologue CyaY exerts a negative regulatory effect on the 
generation of Fe–S instead of its activation role present in 
mammals [50]. The mechanisms and players for the inser-
tion of Fe into the complex need to be elucidated, but it has 
been suggested that Fe is required for the sulfur to be deliv-
ered form NFS1 [51]. Electrons are required for the genera-
tion of the [2Fe–2S] cluster and they are likely transferred 
from NAD(P)H to ferredoxin reductase (FDXR) and onto 
ferredoxin (FDX) [52].
Following its formation by the ISC machinery, the Fe–S 
cluster needs to be transferred to recipient apoproteins. 
Although little is known about this process in mammals, 
evidence based on yeast and bacteria suggests that the chap-
erone HSPA9 (HscA in bacteria) binds to the co-chaperone 
HSC20 (HscB in bacteria) and targets the ISCU complex 
for the release of the [2Fe–2S] cluster, likely mediated by 
a conformational change in ISCU that favours the release 
[53]. It has been proposed that the cluster can be released 
to glutaredoxin 5 (GLRX5), as the yeast Ssq1 has been 
shown to interact with GLRX5 to facilitate the transfer of 
the cluster [54]. This concept is supported by the discov-
ery of [2Fe–2S] clusters buried in human GLRX5 revealed 
by its crystal structure [55]. The complex involved in late 
maturation of [4Fe–4S] clusters is composed of the human 
proteins ISCA1, ISCA2 and IBA57. This complex does not 
interact directly with the initial ISC machinery. The impor-
tance of each component was shown by decreased activity 
of aconitase, lipoic acid synthase, and the complex I of the 
respiratory chain in HeLa cells, where the three proteins 
were downregulated [56]. Finally, the trafficking from the 
ISCA1–ISCA2–IBA57 complex to apoproteins is facilitated 
by NFU1. The bacterial homologue Nfu1 interacts with the 
[4Fe–4S] cluster machinery and target proteins, suggesting 
a similar role for the human protein [57]. Furthermore, the 
Bol1 and Bol3 targeting factors have been involved in the 
maturation of a specific set of [4Fe–4S] proteins [57, 58].
The mechanism of the assembly, trafficking, and matu-
ration of Fe–S clusters has been mainly described by the 
work made with the homologous proteins in both bacteria 
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and yeast, but the relevance of most of these components 
in human physiology is shown by their relation to various 
diseases. In the following sections, we will discuss several 
diseases that have been linked to alterations in components 
involved in Fe–S cluster biogenesis.
Is there a link between mitochondria 
biogenesis components and Fe–S 
biogenesis?
The mitochondria import pathways are critical for mitochon-
dria biogenesis, whilst the Fe–S cluster biogenesis is consid-
ered as one of the most essential functions of mitochondria. 
There are some fragmented studies that suggested a link 
between these two important processes, but whether this is 
true remains unclear. Specifically, the IMS oxidoreductase 
Mia40, one of the two key components for the MIA path-
way responsible for targeting many intermembrane space 
proteins, has been shown (both in vivo and in vitro) to bind 
to iron/sulfur clusters, in addition to its well-established 
role in mitochondria biogenesis [59, 60]. Two monomers 
can coordinate the cluster through the catalytic CPC motif. 
However, it remains unclear whether the presence of Fe–S 
on Mia40 has any relevance for its import function. In mam-
malian cells deletion of Mia40 is associated with increased 
iron levels in mitochondria, but again whether this is a direct 
effect on Fe–S cluster availability/transport or an indirect 
effect of reduced import of some other protein(s) that are 
Mia40-dependent is not known.
Another link of the two processes is through the CIA 
component, Dre2, that has been shown to localize both in 
the cytosol and in mitochondria [61–63]. Dre2 interacts with 
Mia40 independently of the presence of its Fe–S clusters. 
This interaction results in the introduction of two disulfide 
bonds in the Dre2 structure. However, it was later dem-
onstrated that the localization of Dre2 is difficult to prove 
unambiguously as this protein associates tightly with the 
outer membrane of mitochondria and resists proteolytic 
hydrolysis [64]. Even though the role of Dre2 in the cytosol 
as part of the CIA machinery is understood, a putative role 
for a mitochondria-associated sub-population has not been 
determined yet. One could speculate that the mitochondrial 
association may be triggered by specific determinants poten-
tially assisting the delivery of the iron–sulfur clusters from 
the matrix into the cytosol.
Most of the mitochondrial biogenesis pathways are well 
conserved. One exception is the trypanosomatids, a family of 
protozoan parasites. It has been shown that oxidoreductase 
Mia40 is absent from this organism, while the Erv1 homo-
logue seems to take over the entire function of the Mia/Erv1 
pathway [65, 66]. It is not clear how this system in T. brucei 
can operate mechanistically. The investigation of the Fe–S 
cluster export pathway in this organism will be very exciting.
Intriguingly, the initial results that linked lower levels of 
Erv1 in a yeast temperature mutant to a role of this protein 
in Fe–S cluster were later disputed by another study. This 
showed that glutathione levels in this strain were surpris-
ingly lower and it is the effect of the levels of glutathione, 
the apparent cause for the observed defect in Fe–S clus-
ter biogenesis [67]. These authors went to a great extent to 
investigate different strains and conditions relevant to both 
Erv1 and Mia40, and concluded that there is no link of the 
levels of iron to Erv1 or Mia40.
Another case of an iron–sulfur cluster protein that has 
been shown to have mitochondrial association is mitoNEET 
[68]. Specifically, this protein is anchored to the outer mem-
brane facing the cytosol; and even though it has a zinc finger 
domain, it binds to iron, specifically [2Fe–2S] clusters. Many 
studies focus on this protein, as its overexpression is linked 
with various effects, such as enhanced lipid uptake, reduced 
membrane potential, less ROS production, and inhibition 
of iron transport from the cytosol in mitochondria [69]. All 
the above point to a role of mitoNEET as an important mito-
chondrial regulator and an interesting potential target for 
therapies. MitoNEET has already been used as a target of 
the insulin-sensitizing thiazolidinedione diabetes drugs [70].
The case of oxymonad Monocercomonoides 
sp.
Mitochondria are considered in general indispensable for 
viability. Supporting this concept, in the past, there have 
been reports of organisms surviving in low oxygen envi-
ronments with a reduced form of this organelle. Recently, 
however, a very interesting study reported the first case of 
eukaryotic organism completely devoid of mitochondria, 
the oxymonad Monocercomonoides sp. [71]. It appears that 
the absence of mitochondria in this case is not an ancestral 
characteristic, but instead a secondary loss incident. The 
data are based mainly in phylogenetic analysis and genome 
searches for known genes, normally selected as markers in 
mitochondrial studies, for example membrane translocases. 
The searches proved unsuccessful as no such sequences are 
present in the Monocercomonoides sp. genome. Regarding 
the Fe–S cluster biosynthesis pathways, however, this organ-
ism contains a cytosolic sulfur mobilization system (SUF), 
that has been described in bacteria, instead of the mitochon-
drial iron–sulfur cluster assembly pathways (ISC). In addi-
tion to the SUF, the group identified other essential genes for 
glycolytic proteins including enzymes for anaerobic glycoly-
sis, indicating that the mitochondrial absence is solid. Thus, 
the existence of Monocercomonoides sp. highlights a unique 
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exception to the concept that mitochondria are essential for 
viability in all eukaryotes.
Iron sensing and regulation
Well-studied and known reactions that utilise Fe–S clusters 
include the sulfur donors in biosynthesis, the mitochondrial 
electron transport chain reactions, catalysis by aconitase, etc. 
These reactions have been linked with human diseases via 
elevated iron levels, mutations in enzymes, or DNA damage.
As mentioned before, even though iron is vital for the cell 
processes, excess amounts can lead to oxidative damage and 
toxicity. Cells have adapted to address to such a challenge, 
by developing specific mechanisms to strategically regulate 
iron intake, storage, and utilization according to the varia-
tions in cell environment.
Iron regulatory proteins (IRPs) are responsible for con-
trolling the translation of genes involved in those specific 
mechanisms by binding to non-coding sequences of the 
corresponding mRNAs, known as iron-responsive elements 
(IREs). This mechanism depends on the cell iron conditions, 
in addition to structural features of the enzyme [72]. Thus, in 
the presence of high iron levels, IRP1 binds a cubic iron–sul-
fur cluster and function as a cytosolic aconitase. There are 
many dedicated studies on IRP1, their structural features, 
interaction with hypoxia inducing factors that are covered 
in other reviews [73, 74].
Another example is in Saccharomyces cerevisiae, where 
the iron metabolism is regulated by the transcription factors 
Aft1/Aft2 and Yap5, in accordance to the available iron lev-
els [24, 36]. The first two are implicated with the activation 
of genes when the iron levels are low, while Yap5 is involved 
when the iron levels are extremely high. In particular, these 
proteins receive a signal from the mitochondrial ISC, in the 
form of a cluster, and with the help of the monothiol glutar-
edoxins Grx3 and Grx4, they regulate their transcriptional 
function [35, 75–77]. All genes associated with iron sens-
ing and regulation include a specific DNA sequence in their 
promoter, the iron regulatory element (known as IRE), that 
is recognised by the transcription factors.
There are also many indications that tripeptide glu-
tathione (GSH) plays an essential role in cellular iron metab-
olism [78, 79]. Defects in glutathione biosynthesis can lead 
to accumulation of iron in mitochondria [80, 81].
Diseases associated with iron–sulfur clusters
The involvement of iron–sulfur clusters in the vast major-
ity of the cell processes makes it clear that many diseases 
are linked with malfunctions or mutations in pathways that 
include them. Below, we mention some of the many known 
and studied diseases associated with Fe–S pathways, also 
summarised in Table 1.
Friedreich’s ataxia
Friedreich’s ataxia (FRDA) is the most common disease 
associated with dysfunction of Fe–S biogenesis. It is an 
autosomal recessive neurodegenerative disease with an inci-
dence of 1/50,000 in Caucasian population [82]. FRDA is 
caused by a homozygous guanine–adenine–adenine (GAA) 
repeat expansion within the first intron of the frataxin gene 
(FXN) located on the long arm of chromosome 9 [83]. The 
main symptoms have been associated with FRDA dysarthria 
(a motor speech disorder), scoliosis, muscle weakness, and 
loss of position sense. In addition, FRDA can lead to diabe-
tes and cardiomyopathy.
As mentioned before, frataxin is involved in Fe–S clusters 
biogenesis. Thus, alterations linked to iron metabolism are 
present in FRDA. The pathophysiology of FRDA comprises 
deficit of aconitase and respiratory chain complexes, pres-
ence of oxidative damage markers in blood and urine, and 
intracellular iron accumulation [82, 84–86]. Currently, no 
successful treatment is available for FRDA. One main rea-
son for this is the lack of understood detailed understanding 
of mechanisms of Fe–S cluster biogenesis and appropriate 
disease models. However, some treatments involving iron 
chelators like deferiprone are already in clinical trials and 
are listed in the Friedreich’s Ataxia Research Alliance; and 
others are still being developed and tested in animals (i.e., 
gene therapy targeting the FXN gene) [87, 88].
ISCU and FDX2 myopathies
Myopathy is a disorder of skeletal muscles with the pres-
ence of impairment of muscle fibers. The ISCU myopathy 
is an autosomal recessive disorder characterised by exercise 
intolerance that leads to increased lactate and pyruvate con-
centrations and it was first identified in Sweden [89]. This 
disorder is caused by severely reduced levels of ISCU pro-
tein in individuals that share a point mutation in the fourth 
intron of the ISCU gene that causes a premature stop codon. 
This mutation amplifies a polypyrimidine tract (tctttg to 
tctttc), which is normally a weak splice acceptor. As a con-
sequence of this, the strengthened site allows the inclusion 
of an aberrant exon into the transcript [90]. The reduced 
levels of a functional ISCU protein lead to Fe–S clusters 
biogenesis and Fe homeostasis alterations in samples from 
patients [91]. A mutation of a conserved glycine residue into 
glutamate has been shown to interfere with the interaction of 
the scaffold protein with NFS1 and HSC20 [92]. The use of 
specific anti-sense oligonucleotide targeting the ISCU gene 
to correct the reading frame has shown promising results in 
fibroblast derived from patients [93].
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Similar to the ISCU myopathy, mutations in the FDX1L 
gene which disrupts the initiation translation site of the 
FDX2 protein caused proximal muscle myopathy associ-
ated with myoglobinuria and lactic acidosis together with 
reduced activity of aconitase and affected complex II [94].
Infantile complex II/III deficiency
A lethal autosomal recessive disease caused by a mutation 
that leads to substitution of arginine into glutamine in the 
cysteine desulfurase, NFS1, has been identified. It is charac-
terised by lactic acidosis, muscle deficiencies in respiratory 
complex II and III that have as consequence multisystem 
organ failure [95]. Little is known about this disorder as just 
three patients have been reported so far, but its lethality as 
well as the strong impairment of both cytosolic and mito-
chondrial Fe–S proteins in NFS1 knocked down HeLa cells 
stress the importance of the activity of this protein.
Respiratory chain complexes’ deficiency
A homozygous mutation in LYRM4, the gene encoding for 
ISD11, was found in two patients with decreased oxidative 
phosphorylation. The mutation was identified in a patient 
with deficiency of complex I, II, and III in muscle and liver 
by massive parallel sequencing (MitoExome sequencing) 
[96]. The same mutation was identified in another affected 
patient who presented additional complex IV deficiency 
and who died while neonate. The differences between the 
outcomes of both patients are suggested to be due to the 
availability of cysteine in the new-born period. Furthermore, 
in vitro experiments showed no desulfurase activity of NFS1 
when expressed together with mutant ISD11, reflecting the 
importance role of this protein for the stabilisation of the 
desulfurase [96].
X‑linked sideroblastic anemia and ataxia
The ATP-binding cassette, sub-family B, member 7 
(ABCB7) is a membrane associated protein located in 
mitochondria. ABCB7 is a transporter present in the inner 
membrane of mitochondria and its depletion in HeLa cells 
showed Fe accumulation within mitochondria [97]. Muta-
tions in the ABCB7 gene cause a recessive disorder, namely 
X-linked sideroblastic anemia and ataxia (XLSA/A) [98]. 
XLSA/A is an early onset disease characterised by a blood 
disorder in which erythrocytes do not produce enough 
haemoglobin (sideroblastic anemia) and slow-progressive 
movement problems (slow-progressive ataxia) [99]. The 
mutations on XLSA/A patients are in the transmembrane 
domain, but still, complete understanding of ABCB7 func-
tion is needed to fully characterise this disorder and can 
develop a possible cure.
Sideroblastic anemia or variant non‑ketonic 
hyperglycinemia and iron overload
Sideroblastic anemias are a group of heterogeneous disorders 
that share common features like mitochondrial iron overload, 
high numbers of ringed sideroblasts, and affected erythropoie-
sis. Among the different types of sideroblastic anemia, one 
version is caused by a large deletion on the GLRX5 gene. This 
mutation in intron 1 leads to complete loss of GLRX5 protein 
function and the subsequent impairment of Fe–S biogenesis 
together with the activation of the iron-responsive element 
(IRE)-binding activity of iron regulatory protein 1 (IRP1) 
[100].
Multiple mitochondrial dysfunctions syndromes
Multiple mitochondrial dysfunctions syndromes (MMDS) are 
due to mutations in proteins involved in biogenesis of Fe–S 
clusters and are characterised by mitochondria affected at 
multiple levels. MMDS 1 is caused by mutations in affecting 
NFU1 and was first identified in three siblings of Mexican 
origins, while MMDS 2 is the result of a mutation that leads 
to premature stop codon in the BOLA3 gene causing severe 
epileptic encephalopathy and elevated lactate and glycine lev-
els. Finally, MMDS 3 is caused by a homozygous mutation 
that diminishes the activity of IBA57 which leads to defects 
in mitochondrial respiratory complexes I and II [102–105].
Conclusion
Despite the rapid progress in the Fe–S field, there are still 
many unanswered questions regarding the interactions 
between the individual proteins, the formation of complexes, 
the identity or even the presence of an X-S exported material 
from the mitochondria, and the delivery of the clusters into 
the recipient apoproteins. Research in this field will help to 
understand the determinants of many diseases associated with 
iron cluster protein pathways. Furthermore, the development 
of appropriate cell and mouse models for these diseases is 
crucial to further investigate potential therapeutic strategies.
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